Background: Traditional health care systems have evolved to increasingly recognize patients’ perspectives as key to improving the quality of care, especially in oncology. Hence, patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) can enhance patient–health care provider communication while facilitating individualized care. This tailored approach improves patient outcomes and highlights the need for research […]
Blurring the lines of healthcare AI
If you asked me a year ago to break down the different areas of healthcare AI we’re covering, it might’ve looked like scribes, clinical decision support and a whole lot of administrative use cases, like …
Lift for UK healthtech as fund bags £100m from national bank
A new Apposite Capital fund has been set up with £100m to provide much-needed scale-up funding for UK biopharma and healthtech companies.
Using versus selling lucrative PRVs: Moderna’s cautionary tale
As the prices paid for priority review vouchers (PRVs) have crept up over the past year — the last two have sold for at least $200 million each — companies now have to make difficult decisions on …
MSF says Gilead’s lenacapavir supply ‘not nearly enough’; PolyPeptide’s strategic review
Plus, news about Grand River, syringe stockpiling in South Korea and Cellares: 💉 MSF criticizes Gilead’s lenacapavir supply: Gilead is expanding supply of the HIV prevention injection to an additional one …
FDA accelerated approval path needs improvement, says ICER
The FDA’s accelerated approval route has delivered important new drugs to patients quicker, but is opaque and plagued by inconsistencies, says ICER.
Treating enterprise AI as an operating layer
There’s a fault line running through enterprise AI, and it’s not the one getting the most attention. The public conversation still tracks foundation models and benchmarks — GPT versus Gemini, reasoning scores, and marginal capability gains. But in practice, the more durable advantage is structural: who owns the operating layer where intelligence is applied, governed, […]
Making AI operational in constrained public sector environments
The AI boom has hit across industries, and public sector organizations are facing pressure to accelerate adoption. At the same time, government institutions face distinct constraints around security, governance, and operations that set them apart from their business counterparts. For this reason, purpose-built small language models (SLMs) offer a promising path to operationalize AI in […]
Lilly says Foundayo safety confirmed in ACHIEVE-4 trial
Eli Lilly’s ACHIEVE-4 trial results for oral GLP-1 Foundayo set up a filing in diabetes, and provide safety data sought by the FDA.
Why having “humans in the loop” in an AI war is an illusion
The availability of artificial intelligence for use in warfare is at the center of a legal battle between Anthropic and the Pentagon. This debate has become urgent, with AI playing a bigger role than ever before in the current conflict with Iran. AI is no longer just helping humans analyze intelligence. It is now an […]
Lilly’s obesity pill heads for diabetes filing after heart risk trial
Eli Lilly’s recently approved obesity pill Foundayo cut the risk of cardiovascular events like heart attack and stroke by 16% versus a form of insulin, new data show, and the company is planning to file …
Beeline raises $300m for BMS drugs, and other biofinancings
Beeline Medicines, Oricell, Terremoto, Harbinger, Neomorph, Adcendo, and STORM all closed impressive financing rounds in the last week.